eHealth, Inc. (NASDAQ:EHTH) tinted gains of +1.56% (+0.29 points) to US$18.88. The volume of 0.11 Million shares climbed down over an trading activity of 138.98 Million shares. EPS ratio determined by looking at last 12 month figures is -3.39. Over the same time span, the stock marked US$28.59 as its best level and the lowest price reached was US$13.61. The corporation has a market cap of US$357.96 Million.
eHealth, Inc. (NASDAQ:EHTH)’s earnings per share has been growing at a -41.4 percent rate over the past 5 year when average revenue increase was noted as 2.1 percent. The return on equity ratio or ROE stands at -33.8 percent while most common profitability ratio return on investment (ROI) was -8.2 percent. The company’s institutional ownership is monitored at 92.1 percent. The company’s net profit margin has achieved the current level of -46.7 percent and possesses 99.4 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 2 think it is Hold. Recently, analysts have updated the overall rating to 2.4. 3 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
SPS Commerce, Inc. (NASDAQ:SPSC) is worth US$1.26 Billion and has recently risen 1.55% to US$71.19. The latest exchange of 0.16 Million shares is below its average trading activity of 148.85 Million shares. The day began at US$69.93 but the price moved to US$68.95 at one point during the trading and finally capitulating to a session high of US$71.07. The stock tapped a 52-week high of US$72.68 while the mean 12-month price target for the shares is US$71.
Currently, the stock carries a price to earnings ratio of 191.37, a price to book ratio of 4.22, and a price to sales ratio of 5.53. For the past 5 years, the company’s revenue has grown 23.4%, while the company’s earnings per share has grown 32.5%. With an institutional ownership near 0%, it carries an earnings per share ratio of 0.37.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 4 brokerage firms polled by Factset Research. At present, 4 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 3 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.